Skip to main content

Table 7 Fasting Blood Glucose levels: effectiveness of treatments

From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome

 

Blood Glucose (mean mg/dl)

change (%)

 

Initial

8 Weeks

8 Weeks - Initial

Formula B (↑dose)

104.84 ± 9.39

92.06 ± 6.29b*

-12.19

Formula A (↓dose)

105.61 ± 8.62

97.22 ± 7.81a

-7.94

Placebo

107.52 ± 8.73

105.90 ± 10.79

-1.51

  1. ap < 0.05; bp < 0.001; compared with Placebo
  2. *p < 0.05; **p < 0.001 compared with Formula A
  3. p < 0.05; p < 0.001 compared with Initial; intragroup analysis